Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Gross Profit: 2018-2024

Historic Gross Profit for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to $152.3 million.

  • Arcturus Therapeutics Holdings' Gross Profit fell 58.84% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.6 million, marking a year-over-year decrease of 39.15%. This contributed to the annual value of $152.3 million for FY2024, which is 8.69% down from last year.
  • Arcturus Therapeutics Holdings' Gross Profit amounted to $152.3 million in FY2024, which was down 8.69% from $166.8 million recorded in FY2023.
  • Arcturus Therapeutics Holdings' Gross Profit's 5-year high stood at $206.0 million during FY2022, with a 5-year trough of $9.5 million in FY2020.
  • Moreover, its 3-year median value for Gross Profit was $166.8 million (2023), whereas its average is $175.0 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Gross Profit slumped by 54.12% in 2020, and later spiked by 1,566.79% in 2022.
  • Arcturus Therapeutics Holdings' Gross Profit (Yearly) stood at $9.5 million in 2020, then climbed by 29.56% to $12.4 million in 2021, then soared by 1,566.79% to $206.0 million in 2022, then dropped by 19.03% to $166.8 million in 2023, then fell by 8.69% to $152.3 million in 2024.